Details of the Drug Reposition

General Information of This Drug (ID: DMKJ7WA)

Drug Name	ERC-1671 DMKJ7WA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Glioma	DIS5RPEH	2A00.0	Phase 2	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01903330) ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme. U.S. National Institutes of Health.